Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Acquisitions

v3.8.0.1
Note 3 - Acquisitions
3 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Business Combination Disclosure [Text Block]
Note
3
. Acquisitions:
 
We periodically complete business combinations that align with our business strategy.
Acquisitions are accounted for using the acquisition method of accounting, which requires, among other things, that assets acquired and liabilities assumed be recognized at fair value as of the acquisition date and the results of operations of each acquired business are included in our consolidated statements of comprehensive income from their respective dates of acquisition. Acquisition costs are recorded in selling, general and administrative expenses as incurred.
 
Trevigen Inc.
On
September 5
,
2017
the Company acquired the stock of Trevigen Inc. for approximately
$10.6
million, net of cash received. The Company has had a long-standing business relationship with Trevigen as a seller of its product line. The goodwill recorded as a result of the acquisition represents the strategic benefits of growing the Company’s product portfolio and the expected revenue growth from increased market penetration. The goodwill is
not
deductible for income tax purposes. The business became part of the Biotechnology reportable segment in the
first
quarter of fiscal
2018.
 
Certain estimated
fair values are
not
yet finalized and are subject to change, which could be significant. The Company expects to finalize these during fiscal year
2018
when our valuation models for acquired intangible assets are completed, including the determination of related estimated useful lives. Amounts for acquired inventory, intangible assets, and related deferred tax liabilities, and goodwill remain subject to change. The preliminary estimated fair values of the assets acquired and liabilities assumed, are as follows (in thousands):
 
   
Trevigen
 
Current assets, net of cash
  $
1,662
 
Equipment
   
139
 
Other long-term assets
   
15
 
Intangible assets:
       
Developed technology
   
3,800
 
Tradename
   
1,400
 
Customer relationships
   
1,900
 
Goodwill
   
4,595
 
Total assets acquired
   
13,511
 
Liabilities
   
92
 
Deferred income taxes, net
   
2,785
 
Net assets acquired
  $
10,634
 
         
Cash paid, net of cash acquired
  $
10,634
 
 
Tangible assets acquired, net of liabilities assumed, were stated at fair value at the date of acquisitions based on
management's assessment. The purchase price allocated to developed technology, trade names, and customer relationships was based on management's forecasted cash inflows and outflows and using a relief-from-royalty and a multi-period excess earnings method to calculate the fair value of assets purchased. The developed technology is being amortized with the expense reflected in cost of goods sold in the Condensed Consolidated Statement of Earnings and Comprehensive Income. Amortization expense related to trade names, and customer relationships is reflected in selling, general and administrative expenses in the Consolidated Statement of Earnings and Comprehensive Income. The preliminary amortization periods for intangible assets acquired in fiscal
2018
are estimated to be
10
years for developed technology,
12
years for customer relationships, and
1.5
years for trade names. The deferred income tax liability represents the net amount of the estimated future impact of adjustments for costs to be recognized upon the sale of acquired inventory that was written up to fair value and intangible asset amortization, both of which are
not
deductible for income tax purposes.